论文部分内容阅读
为弄清氧气驱动雾化吸入在小儿憋喘性肺炎治疗中的效果,本研究选取2016年3月至6月在本院儿科行雾化吸入治疗的患者136例作为研究对象,使用计算机产生随机数字表,将患者分为实验组和对照组,每组各68例,对照组使用常规超声雾化吸入治疗,实验组使用氧气驱动雾化吸入治疗。试图通过对比雾化吸入治疗后观察患者的临床改善情况、气喘缓解时间、咳嗽消失时间、哮鸣音消失时间以及平均住院天数阐明氧气驱动雾化吸入对治疗小儿喘憋性肺炎的作用。结果表明:实验组患儿临床改善率明显高于对照组(p<0.05),且实验组患者气喘缓解时间,咳嗽消失时间,哮鸣音消失时间以及平均住院天数也明显低于对照组(p<0.01)。显然,本研究结果表明:氧气驱动雾化可以明显改善小儿憋喘性肺炎患儿的临床疗效,缩短患儿症状和体征缓解时间,缩短住院天数,且安全有效,值得临床应用推广。
In order to clarify the effect of aerosol-driven inhalation in the treatment of pediatric asthmatic pneumonia in children, we selected 136 patients with aerosol inhalation therapy in our pediatric department from March to June 2016 as the research object, Digital table, the patients were divided into experimental group and control group, 68 cases in each group, the control group using conventional ultrasonic inhalation therapy, the experimental group using oxygen-driven inhalation therapy. Attempts to clarify the role of oxygen-driven nebulization in the treatment of asthmatic pneumonia in children were compared by observing the patients’ clinical improvement, the time of asthma relief, the time of cough disappearance, the time of wheezing disappearance and the number of days of hospitalization after comparing inhalation therapy. The results showed that the clinical improvement rate of the experimental group was significantly higher than that of the control group (p <0.05), and the asthma relief time, disappearance of cough, disappearance of wheeze and average length of stay in the experimental group were also significantly lower than those in the control group <0.01). Obviously, the results of this study show that: oxygen-driven atomization can significantly improve the clinical efficacy of children with asthmatic pneumonia, shorten the symptoms and signs of children with remission time, shorten the length of stay, and safe and effective, it is worth promoting the clinical application.